-
October 24, 2022 Math Over Myth: Positive Technical Divergences in the Psychedelic SectorMath over Myth is your weekly guide to stocks and ETFs in the psychedelic sector,...
-
October 21, 2022 Empower Psychedelics: Harnessing the Powers of Running on AcidEmpower Psychedelics is raising awareness for physical fitness as a key component of therapeutic recovery...
-
October 21, 2022 Patent Controversies in PsychedelicsWhat investors need to know about the intellectual property behind medicine’s next big growth area
-
October 20, 2022 I Tried At-Home Ketamine Therapy and Here’s What HappenedAt home ketamine therapy offers convenience but also makes you be your own clinician. Is...
-
October 19, 2022 Red Flags to Spot a Bad Psychedelic TherapistPsychedelic therapy is becoming more popular, but here are some red flags you can use...
-
October 18, 2022 A Beginner’s Guide to Amanita muscaria MushroomsThe red mushroom with white spots is a fixture of psychedelic art, but is it...
-
October 17, 2022 Why it’s a Bad Idea to Take Mushrooms on a PlanePsychonauts react to viral story of man who assaulted flight attendants after taking mushrooms on...
-
October 17, 2022 Math Over Myth: Compass and Revive Release Phase 3 Updates but Stocks DropMath over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and...
-
October 14, 2022 Treating Postpartum Depression with PsychedelicsPostpartum depression impacts thousands with no good treatment options. Some people are now treating postpartum...
-
October 13, 2022 Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS,...
